HEALER

It contributes to the healing and cleansing of wounds.

The summary of mint pepper.

It reduces the pain associated with abdominal hemorrhoids.

The active ingredients include the following: white tumor collection.

Cream, applied topically produces a marked reduction in the bacterial population present in the avascular tissues of second.

• and third-degree burns.

Reduction in bacterial growth after application of SULFAMYLON Cream has also been reported to permit spontaneous healing of deep partial-thickness burns, and thus prevent conversion of burn wounds from partial-thickness to full-thickness.

It should be noted, however, that delayed eschar separation has occurred in some cases.

Applied topically, SULFAMYLON Cream diffuses through devascularized areas, is absorbed, and rapidly converted to a metabolite (ρ-carboxybenzenesulfonamide) which is cleared through the kidneys.

SULFAMYLON is active in the presence of pus and serum, and its activity is not altered by changes in the acidity of the environment.

SULFAMYLON exerts bacteriostatic action against many gram-negative and gram-positive organisms, including Pseudomonas aeruginosa and certain strains of anaerobes.

Ointment (English: Neo Healar) is an herbal extract that contains a variety of natural plants and has its anti-inflammatory and aphrodisiac properties.

It is frequently difficult to distinguish between an adverse reaction to SULFAMYLON Cream and the effect of a severe burn.

A single case of bone marrow depression and a single case of acute attack of porphyria have been reported following therapy with SULFAMYLON Cream.

Fatal hemolytic anemia with disseminated intravascular coagulation, presumably related to a glucose-6-phosphate dehydrogenase deficiency, has been reported following therapy with SULFAMYLON Cream.

The most frequently reported reaction was pain on application or a burning sensation.

Rare occurrences are excoriation of new skin and bleeding of skin.

Rash itching, facial edema, swelling, hive, blisters, erythema, and eosinophilia.

Tachypnea or hyperventilation, decrease in arterial pCO 2.

Acidosis, increase in serum chloride.

Accidental ingestion of SULFAMYLON

Cream has been reported to cause diarrhea.

To report SUSPECTED ADVERSE

REACTIONS, contact Rising Pharma Holdings, Inc.fda.gov/medwatch.

The summary of

Indian veterinary medicine.

Fatal hemolytic anemia with disseminated intravascular coagulation, presumably related to a glucose-6-phosphate dehydrogenase deficiency, has been reported following therapy with SULFAMYLON Cream.

Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people.

The overall prevalence of sulfite sensitivity in the general population is unknown and probably low.

Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

is contraindicated in patients who are hypersensitive to it.

It is not known whether there is cross sensitivity to other sulfonamides.

Prompt institution of appropriate measures for controlling shock and pain is of prime importance.

The burn wounds are then cleansed and debrided, and SULFAMYLON Cream is applied with a sterile gloved hand.

Satisfactory results can be achieved with application of the cream once or twice daily, to a thickness of approximately 1/16 inch; thicker application is not recommended.

The burned areas should be covered with SULFAMYLON Cream at all times.

Therefore, whenever necessary, the cream should be reapplied to any areas from which it has been removed (e.g., by patient activity).

The routine of administration can be accomplished in minimal time, since dressings usually are not required, if individual patient demands make them necessary, however, only a thin layer of dressings should be used.

When feasible, the patient should be bathed daily to aid in debridement.

A whirlpool bath is particularly helpful, but the patient may be bathed in bed or in a shower.

The duration of therapy with SULFAMYLON

Cream depends on each patient’s requirements.

Treatment is usually continued until healing is progressing well or until the burn site is ready for grafting.

Cream should not be withdrawn from the therapeutic regimen while there is the possibility of infection.

However, if allergic manifestations occur during treatment with SULFAMYLON Cream, discontinuation of treatment should be considered.

If acidosis occurs and becomes difficult to control, particularly in patients with pulmonary dysfunction, discontinuing therapy SULFAMYLON Cream for to 48 hours while continuing fluid therapy may aid in restoring acid-base balance.

Jar (453.6 g).

• NDC 16571-723-48 4 oz.

Tube (113.4 g).

• NDC 16571-723-12 2 oz.

Tube (56.7 g).

• NDC 16571-723-60 Avoid exposure to excessive heat (temperature above 104° F or 40° C).

Keep this and all medications out of the reach of children.

Rx only Manufactured for

Brunswick, NJ 08816 Revised: 08/2020 PIR72348-00.